Login / Signup

A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity.

Tim S GrantDarren BurnsChristopher KiffDawn Lee
Published in: PharmacoEconomics (2021)
This case study suggests cure modelling works well with data in which the disease-specific events have had time to occur. Care is needed when extrapolating from immature data, and further information should support the estimation rather than relying on statistical estimates based on the trial alone.
Keyphrases
  • electronic health record
  • big data
  • healthcare
  • clinical trial
  • study protocol
  • data analysis
  • quality improvement
  • open label
  • phase ii